amyloid-related imaging abnormalities (ARIAs) → απεικονιστικές ανωμαλίες σχετιζόμενες με το αμυλοειδές
Amyloid-related imaging abnormalities (ARIA) are abnormal differences seen in magnetic resonance imaging of the brain in patients with Alzheimer's disease. ARIA is associated with amyloid-modifying therapies, particularly human monoclonal antibodies such as aducanumab. There are two types of ARIA: ARIA-E and ARIA-H. The phenomenon was first seen in trials of bapineuzumab.
Amyloid-related imaging abnormalities - Wikipedia